Literature DB >> 20615169

T but not N stage predicts survival for patients with tonsillar carcinoma treated with external radiotherapy and brachytherapy.

Luaay Aziz1, Jan Nyman, Staffan Edström.   

Abstract

BACKGROUND: Our aim was to determine the efficacy of a therapeutic schedule including external radiation and brachytherapy in a consecutive and retrospective series of tonsillar carcinoma patients. PATIENTS AND METHODS: Ninety-six patients with tonsillar carcinoma were treated between 1988 and 2000 and were followed up for at least for three years. All patients were treated with accelerated hyperfractionated external radiotherapy, 68 patients had additional brachytherapy and 69 patients with advanced stages also received chemotherapy. There was no planned surgery even though 73% had N+ disease. Eleven patients with persistent neck nodes underwent ultimate salvage surgery.
RESULTS: The overall three-year survival (OS) was 70%. OS for the T stage was T1 90%, T2 89%, T3 54% and T4 60%. The corresponding numbers for the N stage were N0 61.5%, N1 73%, N2 78% and N3 66%. Accordingly OS was influenced by the T stage (p>0.001) rather than by N stage. Only four patients with salvage surgery had viable tumour cells in the specimen, their survival was not inferior. DISCUSSION: The primary tumour stage is an essential determinant for survival in patients with irradiated tonsillar carcinoma. Neck dissection should be confined only as a salvage procedure.

Entities:  

Mesh:

Year:  2010        PMID: 20615169     DOI: 10.3109/02841860903490085

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  2 in total

1.  Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.

Authors:  Nai-Ming Cheng; Joseph Tung-Chieh Chang; Chung-Guei Huang; Din-Li Tsan; Shu-Hang Ng; Hung-Ming Wang; Chun-Ta Liao; Chien-Yu Lin; Cheng-Lung Hsu; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-02       Impact factor: 9.236

2.  Additional parameters to improve the prognostic value of the 8th edition of the UICC classification for human papillomavirus-related oropharyngeal tumors.

Authors:  Jos M J A A Straetmans; Marijn Stuut; Martin Lacko; Frank Hoebers; Ernst-Jan M Speel; Bernd Kremer
Journal:  Head Neck       Date:  2022-05-17       Impact factor: 3.821

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.